BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25157583)

  • 1. A comprehensive evaluation of fasting serum gastrin-17 as a predictor of diseased stomach in Chinese population.
    Sun L; Tu H; Liu J; Gong Y; Xu Q; Jing J; Dong N; Yuan Y
    Scand J Gastroenterol; 2014 Oct; 49(10):1164-72. PubMed ID: 25157583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study.
    Sipponen P; Ranta P; Helske T; Kääriäinen I; Mäki T; Linnala A; Suovaniemi O; Alanko A; Härkönen M
    Scand J Gastroenterol; 2002 Jul; 37(7):785-91. PubMed ID: 12190091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
    Cao Q; Ran ZH; Xiao SD
    J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting the serum gastrin 17 level: an evidence-based analysis of 3906 serum samples among Chinese.
    Zhang Z; Sun Lp; Gong YH; Wang XG; Zhang M; Yuan Y
    J Dig Dis; 2007 May; 8(2):72-6. PubMed ID: 17532818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between Helicobacter pylori infection, atrophic gastritis and gastric carcinoma in a Japanese population.
    Asaka M; Kato M; Kudo M; Katagiri M; Nishikawa K; Yoshida J; Takeda H; Miki K
    Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S7-10. PubMed ID: 8574741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of H. pylori infection and atrophic gastritis among symptomatic and dyspeptic adults in Kazakhstan. A hospital-based screening study using a panel of serum biomarkers.
    Benberin V; Bektayeva R; Karabayeva R; Lebedev A; Akemeyeva K; Paloheimo L; Syrjänen K
    Anticancer Res; 2013 Oct; 33(10):4595-602. PubMed ID: 24123036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori and CagA status, serum gastrin, interleukin-8 and gastric acid secretion in gastric cancer.
    Konturek SJ; Starzynska T; Konturek PC; Karczewska E; Marlicz K; Lawniczak M; Jaroszewicz-Heigelman H; Bielanski W; Hartwich A; Ziemniak A; Hahn EG
    Scand J Gastroenterol; 2002 Aug; 37(8):891-8. PubMed ID: 12229962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population.
    Zhang L; Blot WJ; You WC; Chang YS; Kneller RW; Jin ML; Li JY; Zhao L; Liu WD; Zhang JS; Ma JL; Samloff IM; Correa P; Blaser MJ; Xu GW; Fraumeni JF
    Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):627-30. PubMed ID: 8824365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of gastrin in gastric cancerogenesis in Helicobacter pylori infected humans.
    Konturek PC; Konturek SJ; Bielanski W; Karczewska E; Pierzchalski P; Duda A; Starzynska T; Marlicz K; Popiela T; Hartwich A; Hahn EG
    J Physiol Pharmacol; 1999 Dec; 50(5):857-73. PubMed ID: 10695565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
    Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic values of serum levels of pepsinogens and gastrin-17 for screening gastritis and gastric cancer in a high risk area in northern Iran.
    Nejadi-Kelarijani F; Roshandel G; Semnani S; Ahmadi A; Faghani B; Besharat S; Akhavan-Tabib A; Amiriani T
    Asian Pac J Cancer Prev; 2014; 15(17):7433-6. PubMed ID: 25227854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of a serological panel test in the assessment of gastritis in symptomatic children.
    de Angelis GL; Cavallaro LG; Maffini V; Moussa AM; Fornaroli F; Liatopoulou S; Bizzarri B; Merli R; Comparato G; Caruana P; Cavestro GM; Franzé A; Di Mario F
    Dig Dis; 2007; 25(3):206-13. PubMed ID: 17827941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum pepsinogen levels and their influencing factors: a population-based study in 6990 Chinese from North China.
    Sun LP; Gong YH; Wang L; Yuan Y
    World J Gastroenterol; 2007 Dec; 13(48):6562-7. PubMed ID: 18161928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological markers for gastric atrophy in asymptomatic patients infected with Helicobacter pylori.
    Ricci C; Vakil N; Rugge M; Gatta L; Perna F; Osborn JF; Russo VM; Tampieri A; Bernabucci V; Miglioli M; Vaira D
    Am J Gastroenterol; 2004 Oct; 99(10):1910-5. PubMed ID: 15447749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive evaluation of Helicobacter pylori therapy: role of fasting or postprandial gastrin, pepsinogen I, pepsinogen II, or serum IgG antibodies.
    Al-Assi MT; Miki K; Walsh JH; Graham DP; Asaka M; Graham DY
    Am J Gastroenterol; 1999 Sep; 94(9):2367-72. PubMed ID: 10483993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between precancerous gastric lesions and serum pepsinogens, serum gastrin, vascular endothelial growth factor, serum interleukin-1 Beta, serum toll-like receptor-4 levels and Helicobacter pylori Cag A status.
    Yakut M; Örmeci N; Erdal H; Keskin O; Karayel Z; Tutkak H; Soykan I
    Clin Res Hepatol Gastroenterol; 2013 Jun; 37(3):302-11. PubMed ID: 23137754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum gastrin, pepsinogens, parietal cell and Helicobacter pylori antibodies in patients with gastric polyps.
    Bonilla Palacios JJ; Miyazaki Y; Kanayuma S; Yasunaga Y; Matsuzawa Y
    Acta Gastroenterol Latinoam; 1994; 24(2):77-82. PubMed ID: 7817697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of IgG1 and IgG2 subclasses to Helicobacter pylori in subjects with chronic inflammation of the gastric mucosa, atrophy and gastric cancer in a country with high Helicobacter pylori infection prevalence.
    Vorobjova T; Ren Z; Dunkley M; Clancy R; Maaroos HI; Labotkin R; Kull K; Uibo R
    APMIS; 2006 May; 114(5):372-80. PubMed ID: 16725014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypergastrinemia after Helicobacter pylori infection is associated with bacterial load and related inflammation of the oxyntic corpus mucosa.
    Chuang CH; Sheu BS; Yang HB; Kao AW; Cheng HC; Yao WJ
    J Gastroenterol Hepatol; 2004 Sep; 19(9):988-93. PubMed ID: 15304114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk of gastric cancer dependent on serological markers of atrophic gastritis: cohort study].
    Reshetnikov OV; Openko TG; Simonova GI; Kurilovich SA; Maliushina SK; Ragino IuI; Voevoda MI
    Vopr Onkol; 2012; 58(5):644-8. PubMed ID: 23600281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.